Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study : Journal of the American Society of Nephrology

Journal Logo

Clinical Research

Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study

Uhlin, Fredrik1,2; Szpirt, Wladimir3; Kronbichler, Andreas4; Bruchfeld, Annette1,5; Soveri, Inga6; Rostaing, Lionel7; Daugas, Eric8; Lionet, Arnaud9; Kamar, Nassim10; Rafat, Cédric11; Mysliveček, Marek12; Tesař, Vladimír12; Fernström, Anders1; Kjellman, Christian13; Elfving, Charlotte13; McAdoo, Stephen14; Mölne, Johan15; Bajema, Ingeborg16; Sonesson, Elisabeth13; Segelmark, Mårten1,17

Author Information
JASN 33(4):p 829-838, April 2022. | DOI: 10.1681/ASN.2021111460
  • Buy
  • Infographic
  • SDC

Abstract

Copyright © 2022 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid